Search Within

Gary Schwartz

  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (55)
  2. Meeting Abstract (42)
  3. Book Section (1)
  4. Conference Paper (1)
Groups
  1. Department of Medicine (99)
  2. Gastrointestinal Oncology Service (99)
  3. Solid Tumor Oncology Division (99)
  4. Center for Pancreatic Cancer Research (88)
  5. Biostatistics Service (24)
  6. Epidemiology and Biostatistics (24)

More Groups

People
  1. David Kelsen (79)
  2. Eileen O'Reilly (36)
  3. Leonard Saltz (30)
  4. Manish Shah (26)
  5. David Ilson (23)
  6. Nancy Kemeny (17)

More People

Years
  1. 2013 (4)
  2. 2012 (4)
  3. 2011 (1)
  4. 2010 (2)
  5. 2009 (3)
  6. 2008 (4)

More Years

Publications
  1. Journal of Clinical Oncology (29)
  2. Clinical Cancer Research (12)
  3. Cancer (9)
  4. Annals of Oncology (6)
  5. Proceedings of the American Association for Cancer Research Annual Meeting (6)
  6. Annals of Surgical Oncology (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (29)
  2. American Association for Cancer Research (18)
  3. Springer (11)
  4. Oxford University Press (10)
  5. Wiley Blackwell (10)
  6. Elsevier Inc. (7)

More Publishers

Results (99)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase IB clinical trial of the sequence dependent combination of paclitaxel (P) and cisplatin (C) with the cyclin dependent kinase (CDK) inhibitor flavopiridol in patients with advanced solid tumors
    Meeting Abstract

    Shah, M. A.; Kaubisch, A.; O'reilly, E.; Sharma, S.; Endres, S.; Welch, M.; Tong, W.; Spriggs, D.; Schwartz, G. K.
    Proceedings of the American Association for Cancer Research Annual Meeting (2001)

    Fulltext@MSK | Save
  • Low Drg1 expression indicates poor survival in patients with metastatic colon cancer
    Meeting Abstract

    Shah, M. A.; Schwartz, G. K.; Drobnjak, M.; Motwani, M. V.; Hummer, A.; Gonen, M.; Cordon-Cardo, C.; Kemeny, N.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • A phase I/pharmacologic study of UCN-01 in combination with 5-fluorouracil in patients with advanced solid tumors
    Meeting Abstract

    Shah, M. A.; Kortmansky, J.; Kelsen, D. P.; Hseuh, C.; Kaubisch, A.; Spriggs, D.; Gonen, M.; Tong, W.; Endres, S.; Schwartz, G. K.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma
    Journal Article

    Schwartz, G. K.; Ilson, D.; Saltz, L.; O'reilly, E.; Tong, W.; Maslak, P.; Werner, J.; Perkins, P.; Stoltz, M.; Kelsen, D.
    Journal of Clinical Oncology (2001)

    Fulltext@MSK | Save
  • Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeks
    Journal Article

    Sharma, S.; Kemeny, N.; Schwartz, G. K.; Kelsen, D.; O'reilly, E.; Ilson, D.; Coyle, J.; De Jager, R. L.; Ducharme, M. P.; Kleban, S.; more...
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • A phase II study of irinotecan in patients with advanced hepatocellular carcinoma
    Journal Article

    O'Reilly, E. M.; Stuart, K. E.; Sanz-Altamira, P. M.; Schwartz, G. K.; Steger, C. M.; Raeburn, L.; Kemeny, N. E.; Kelsen, D. P.; Saltz, L. B.
    Cancer (2001)

    Fulltext@MSK | Save
  • Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer
    Journal Article

    Culliford, A. T. 4th; Brooks, A. D.; Sharma, S.; Saltz, L. B.; Schwartz, G. K.; O'Reilly, E. M.; Ilson, D. H.; Kemeny, N. E.; Kelsen, D. P.; Guillem, J. G.; more...
    Annals of Surgical Oncology (2001)

    Fulltext@MSK | Save
  • Gemcitabine and irinotecan in advanced gastrointestinal malignancies
    Meeting Abstract

    O'Reilly, E. M.; Schwartz, G. K.; Ilson, D. H.; Kemeny, N. K.; Saltz, L. B.; Kelsen, D. P.
    Cancer Investigation (2000)

    Fulltext@MSK | Save
  • A phase II study of exatecan mesylate (DX-8951f) in advanced pancreatic cancer
    Meeting Abstract

    O'Reilly, E.; Hammond, L.; Donehower, R.; Schwartz, G.; Kelvin, J.; Aird, S.; Sharma, S.; Schrag, D.; Molloy, K.; De Jager, R.
    Annals of Oncology (2000)

    Fulltext@MSK | Save
  • Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis
    Journal Article

    Hsueh, C. T.; Chiu, C. F.; Kelsen, D. P.; Schwartz, G. K.
    Cancer Chemotherapy and Pharmacology (2000)

    Fulltext@MSK | Save